Robin Berger, MD
Procedural Dermatology · St George, UTNPI 1275557407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 26.6% of the total. Reporting peaked in 2019 at $417 and has fallen 52.8% since, to $197 in 2025.
Across 38 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$262
- Pfizer$165
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$116
- Amgen$68
- Bristol Myers Squibb$58
- Biofrontera Inc.$51
- plus $266 from 9 others
What the payments were for
- Food & beverage$93395%
- Education$535%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $262 |
| Pfizer | 6 | $165 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $116 |
| Amgen | 3 | $68 |
| Bristol Myers Squibb | 1 | $58 |
| Biofrontera Inc. | 2 | $51 |
| Novartis | 1 | $46 |
| Johnson & Johnson | 1 | $43 |
| UCB, Inc. | 2 | $43 |
| Dermavant Sciences, Inc. | 2 | $34 |
| Medtronic | 1 | $24 |
| Sanofi | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Merz North America, Inc. | 1 | $12 |
How this compares
Too few procedural dermatology providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $53,123 |
| Dupixent PenDupilumab | 12 | $44,361 |
| Triamcinolone Acetonide | 153 | $2,312 |
| Doxycycline Monohydrate | 66 | $1,867 |
| Betamethasone Dipropionate | 66 | $1,764 |
| Imiquimod | 99 | $1,429 |
| Fluocinonide | 49 | $1,397 |
| Fluorouracil | 20 | $1,336 |
| Clobetasol Propionate | 29 | $1,317 |
| ValacyclovirValacyclovir Hcl | 53 | $1,174 |
| Metronidazole | 30 | $1,095 |
| Fluocinolone Acetonide | 27 | $985 |
| Ketoconazole | 49 | $778 |
| Hydroxyzine Hcl | 38 | $688 |
| Minoxidil | 76 | $529 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in St George
- Karl TrimbleSt George$505
- Douglas HeinerWest Jordan$3K
- Richard ParkinsonProvo$3K
- Steven EyreOrem$1K
- Rulon BradleySalt Lake City$287
- Paul HarrisonSandy$175
- Willard MaughanSouth Ogden$162
- Leo SotiriouSalt Lake City$29
- Nathan HansonLogan$22
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.